BATS:WDNA WisdomTree BioRevolution Fund (WDNA) Price, Holdings, & News $14.38 +1.12 (+8.43%) Closing price 09/15/2025 01:04 PM EasternExtended Trading$14.38 0.00 (0.00%) As of 09/15/2025 04:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock About WisdomTree BioRevolution Fund (BATS:WDNA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get WDNA alerts:Sign Up Key Stats Today's Range$12.87▼$13.1450-Day Range$13.35▼$15.0652-Week Range$11.20▼$17.22Volume465 shsAverage Volume948 shsMarket Capitalization$2.16 millionAssets Under Management$2.18 millionDividend Yield0.76%Net Expense Ratio0.45%Aggregate RatingModerate Buy ETF Overview The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree. Read More WisdomTree BioRevolution Fund ExpensesTypeWDNATheme ETFsEquity ETFsBATS ETFsAll ETFsManagement Fee0.45%0.57%0.56%0.57%0.53%Other Expenses0.00%0.57%0.56%0.48%0.56%Total Expense0.45%0.74%0.76%0.71%0.73%Fee Waiver0.00%-0.76%-0.66%-0.46%-0.63%Net Expense0.45%0.60%0.63%0.64%0.60% Receive WDNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for WisdomTree BioRevolution Fund and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. WDNA ETF News HeadlinesWisdomTree BioRevolution Fund (BATS:WDNA) Stock Price Up 11.7% - Still a Buy?September 12, 2025 | americanbankingnews.comWisdomTree Floating Rate Trsy Dgtl N/AMarch 29, 2025 | morningstar.comMOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next ChatGPT models, and Porter Stansberry says the real opportunity isn’t in flashy AI apps but in the infrastructure behind them — data centers, fiber networks, energy, and more — with eight companies best positioned to profit from this massive shift. | Porter & Company (Ad)EPS WisdomTree U.S. LargeCap Fund ETFFebruary 5, 2025 | seekingalpha.comWisdomTree BioRevolution Fund declares annual distribution of $0.1071December 27, 2024 | msn.com2024 Superconvergence BioRevolution Series: A New Therapy For Diabetes?October 16, 2024 | seekingalpha.comSee More Headlines WDNA ETF - Frequently Asked Questions How have WDNA shares performed this year? WisdomTree BioRevolution Fund's stock was trading at $14.3659 on January 1st, 2025. Since then, WDNA shares have increased by 0.1% and is now trading at $14.38. Who are WisdomTree BioRevolution Fund's major shareholders? WisdomTree BioRevolution Fund's top institutional shareholders include Jane Street Group LLC (11.24%) and Flow Traders U.S. LLC (10.97%). How do I buy shares of WisdomTree BioRevolution Fund? Shares of WDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of WisdomTree BioRevolution Fund own? Based on aggregate information from My MarketBeat watchlists, some other companies that WisdomTree BioRevolution Fund investors own include NIO (NIO), Insight Select Income Fund (INSI), Merck & Co., Inc. (MRK), iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX), ARK Autonomous Technology & Robotics ETF (ARKQ), ARK Genomic Revolution ETF (ARKG) and Ardelyx (ARDX). Fund Details IssuerWisdomTree Fund NameWisdomTree BioRevolution Fund Tax ClassificationRegulated Investment Company Stock ExchangeBATSCurrent SymbolBATS:WDNA Inception Date6/3/2021 Fund ManagerMarlene Walker-Smith, Thomas J. Durante WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkWisdomTree BioRevolution Index CategoryStrategy FocusTheme Development LevelDeveloped Markets RegionGlobal Number of Holdings98 Fund Statistics Assets Under Management$2.18 million Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorWisdomTree Asset Management, Inc. CustodianState Street Bank and Trust Company DistributorForeside Fund Services, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerFlow Traders Miscellaneous Outstanding Shares150,000Beta1.01 Creation Fee$500.00 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report Top 10 WDNA HoldingsIntellia Therapeutics (NASDAQ:NTLA)Holding Weight: 2.99%CRISPR Therapeutics (NASDAQ:CRSP)Holding Weight: 2.71%Natera (NASDAQ:NTRA)Holding Weight: 2.62%Ginkgo Bioworks (NYSE:DNA)Holding Weight: 2.52%Novozymes A/SHolding Weight: 2.36%Arcturus Therapeutics (NASDAQ:ARCT)Holding Weight: 2.30%Stoke Therapeutics (NASDAQ:STOK)Holding Weight: 2.30%United Therapeutics (NASDAQ:UTHR)Holding Weight: 2.16%Ionis Pharmaceuticals (NASDAQ:IONS)Holding Weight: 2.14%Eli Lilly and Company (NYSE:LLY)Holding Weight: 2.13%Full Holdings DetailsWDNA Sector ExposureWDNA Industry Exposure This page (BATS:WDNA) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WisdomTree BioRevolution Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share WisdomTree BioRevolution Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
